ReviewMolecules (Basel, Switzerland)2026
Essential Oil-Containing Mouthrinses for Plaque and Gingivitis Control: Formulation Chemistry, Human Salivary Biomarkers, Mechanistic Evidence, and Research Priorities.
Review in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Selected essential oil (EO)-containing mouthrinses improve plaque and gingivitis control when used alongside mechanical oral hygiene, but their molecular effects in human saliva remain poorly defined. This narrative review integrates formulation chemistry, oral exposure, human salivary evidence, and mechanistic studies. Three studies identified in this review evaluated salivary immunoglobulin A, immunoglobulin G, or interleukin-1β. Differences in populations, co-interventions, sampling, and analytical methods limit comparison and do not establish reproducible modulation of a single biomarker. Other human studies assessed salivary flow, pH, proteomic responses, microbial counts, nitrate reduction, and oral biofilms. Mechanistic evidence largely derives from isolated constituents in cellular, animal, or computational models. A study of a complete zinc-containing formulation in human oral cells provides formulation-level evidence, but neither this study nor the constituent literature establishes target engagement after mouthrinsing in humans. Future trials should connect chemically characterized formulations and measured oral exposure with target-specific assays, validated salivary endpoints, microbial function, clinical outcomes, and safety. Current evidence supports selected formulations for plaque and gingivitis control; it does not establish an EO class effect or a validated salivary mechanism of clinical benefit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.